Comparing The Efficacy Of An Anti-Human VEGF-A Neutralizing Antibody Versus Bevacizumab On A Laser-Induced Choroidal Neovascularization (CNV) Rhesus Monkey Model

Overview of attention for article published in Drug Design, Development and Therapy, November 2019

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 15 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 3,140 followers.

Comparing The Efficacy Of An Anti-Human VEGF-A Neutralizing Antibody Versus Bevacizumab On A Laser-Induced Choroidal Neovascularization (CNV) Rhesus Monkey Model. https://t.co/whn53ZScLU

04 Jun 2020

Reply Repost Favourite

Comparing The Efficacy Of An Anti-Human VEGF-A Neutralizing Antibody Versus Bevacizumab On A Laser-Induced Choroidal Neovascularization (CNV) Rhesus Monkey Model. https://t.co/whn53ZScLU

07 Dec 2019

Reply Repost Favourite

✅ Comparing The Efficacy Of An Anti-Human VEGF-A Neutralizing Antibody V | DDDT - Dove Medical Press 👌 👉 https://t.co/w5LZvkRuZD 🚩 #Medical #GroupZirigoza

05 Nov 2019

Reply Repost Favourite

Dove Medical Press

Article Metrics

Comparing The Efficacy Of An Anti-Human VEGF-A Neutralizing Antibody Versus Bevacizumab On A Laser-Induced Choroidal Neovascularization (CNV) Rhesus Monkey Model

Mentioned by

Citations

Readers on